Depixus logo

Depixus

See biology as it happens

47 employees · est. 2012 · Courbevoie, France

VS
PROTEINA logo

PROTEINA

Our Protein-protein interaction (PPI) analysis platform enables quantitative measurements at the single-molecule level

32 employees · est. 2015 · Seoul, Korea South

Depixus is the older company (2012 vs 2015).

Side-by-Side Comparison

Depixus PROTEINA
Founded
2012 older 2015
Headquarters
Courbevoie, France Seoul, Korea South
Employees
47 32
Industry
Biotechnology Biotechnology, Health Care, Life Sciences
Funding Stage
Series A Series C
Total Funding
$33.59M $19.00B
Funding Rounds
4 2
Services
MAGNA One equipment, Real-time biomolecular interaction analysis, Parallel interaction analysis, Scientific publications and application notes Not tracked yet
Target Customers
Research institutions, Biochemists, Molecular biologists, Life science researchers, Academic labs, Biotechnology companies Not tracked yet
Taxonomy
Life Science Technology, Magnetic Force Spectroscopy, Biomolecular Interactions, Real-Time Analysis, Genome Analysis, DNA Analysis, RNA Analysis, Single Molecule Precision, RNA Drug Discovery, Protein-Protein Interaction, Biophysics, Drug Discovery, Compound Screening, Interactomics Protein-protein Interaction, PPI Analysis, Single-molecule Co-immunoprecipitation, Quantitative Measurements, Drug Efficacy Modeling, Protein Analysis, Disease Diagnostics, Drug Discovery, Biotech Startup, Molecular Analysis, Diagnostic Technology, Pharmaceutical Research, Biomedical Innovation
Website
depixus.com proteina.co.kr
Depixus logo

About Depixus

Depixus, a Paris-based life science technology company, is redefining the biotechnology landscape with its pioneering technology in magnetic force spectroscopy. This cutting-edge solution enables real-time analysis of individual biomolecular interactions on a vast scale, offering new avenues for res...

PROTEINA logo

About PROTEINA

PROTEINA is a biotechnology startup based in South Korea, founded in 2015. The company has revolutionized protein analysis with its first-in-class protein-protein interaction (PPI) analysis platform, utilizing proprietary 'single-molecule co-immunoprecipitation' technology for quantitative measureme...

We will tell you when either one moves

BounceWatch watches Depixus and PROTEINA for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Depixus and PROTEINA — by email.

Frequently Asked Questions

Depixus — See biology as it happens. PROTEINA — Our Protein-protein interaction (PPI) analysis platform enables quantitative measurements at the single-molecule level. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Depixus has raised $33.59M while PROTEINA has raised $19.00B.
Depixus and PROTEINA operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Depixus with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Depixus on 17 Sep 2025, and PROTEINA on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy